Cargando…

The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling

Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can act...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xiaoxue, Hu, Hui, Qiao, Yi, Xu, Pengfei, Yang, Mengqi, Dang, Ruili, Han, Wenxiu, Guo, Yujin, Chen, Dan, Jiang, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454872/
https://www.ncbi.nlm.nih.gov/pubmed/31001119
http://dx.doi.org/10.3389/fphar.2019.00318
_version_ 1783409620953333760
author Gong, Xiaoxue
Hu, Hui
Qiao, Yi
Xu, Pengfei
Yang, Mengqi
Dang, Ruili
Han, Wenxiu
Guo, Yujin
Chen, Dan
Jiang, Pei
author_facet Gong, Xiaoxue
Hu, Hui
Qiao, Yi
Xu, Pengfei
Yang, Mengqi
Dang, Ruili
Han, Wenxiu
Guo, Yujin
Chen, Dan
Jiang, Pei
author_sort Gong, Xiaoxue
collection PubMed
description Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can activate each other, forming a positive feedback loop that would result in exacerbated unwanted tissue damage. To further examine the interrelationship among insulin signaling, neuroinflammation and RAS in the brain, the effect of repeated lipopolysaccharide (LPS) exposure and co-treatment with the angiotensin II (Ang II) receptor type 1 (AT1) blocker, candesartan (Cand), on anxiety and depression-like behaviors, RAS, neuroinflammation and insulin signaling was explored. Our results demonstrated that prolonged LPS challenge successfully induced the rats into anxiety and depression-like state, accompanied with significant neural apoptosis and neuroinflammation. LPS also activated RAS as evidenced by the enhanced angiotensin converting enzyme (ACE) expression, Ang II generation and AT1 expression. However, blocking the activated RAS with Cand co-treatment conferred neurobehavioral protective properties. The AT1 blocker markedly ameliorated the microglial activation, the enhanced gene expression of the proinflammatory cytokines and the overactivated NF-κB signaling. In addition, Cand also mitigated the LPS-induced disturbance of insulin signaling with the normalized phosphorylation of serine 307 and tyrosine 896 of insulin receptor substrate-1 (IRS-1). Collectively, the present study, for the first time, provided the direct evidence indicating that the inflammatory condition may interact with RAS to impede brain insulin pathway, resulting in neurobehavioral damage, and inhibiting RAS seems to be a promising strategy to block the cross-talk and cut off the vicious cycle between RAS and immune system.
format Online
Article
Text
id pubmed-6454872
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64548722019-04-18 The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling Gong, Xiaoxue Hu, Hui Qiao, Yi Xu, Pengfei Yang, Mengqi Dang, Ruili Han, Wenxiu Guo, Yujin Chen, Dan Jiang, Pei Front Pharmacol Pharmacology Brain insulin signaling is accounted for the development of a variety of neuropsychiatric disorders, such as anxiety and depression, whereas both inflammation and the activated renin-angiotensin system (RAS) are two major contributors to insulin resistance. Intriguingly, inflammation and RAS can activate each other, forming a positive feedback loop that would result in exacerbated unwanted tissue damage. To further examine the interrelationship among insulin signaling, neuroinflammation and RAS in the brain, the effect of repeated lipopolysaccharide (LPS) exposure and co-treatment with the angiotensin II (Ang II) receptor type 1 (AT1) blocker, candesartan (Cand), on anxiety and depression-like behaviors, RAS, neuroinflammation and insulin signaling was explored. Our results demonstrated that prolonged LPS challenge successfully induced the rats into anxiety and depression-like state, accompanied with significant neural apoptosis and neuroinflammation. LPS also activated RAS as evidenced by the enhanced angiotensin converting enzyme (ACE) expression, Ang II generation and AT1 expression. However, blocking the activated RAS with Cand co-treatment conferred neurobehavioral protective properties. The AT1 blocker markedly ameliorated the microglial activation, the enhanced gene expression of the proinflammatory cytokines and the overactivated NF-κB signaling. In addition, Cand also mitigated the LPS-induced disturbance of insulin signaling with the normalized phosphorylation of serine 307 and tyrosine 896 of insulin receptor substrate-1 (IRS-1). Collectively, the present study, for the first time, provided the direct evidence indicating that the inflammatory condition may interact with RAS to impede brain insulin pathway, resulting in neurobehavioral damage, and inhibiting RAS seems to be a promising strategy to block the cross-talk and cut off the vicious cycle between RAS and immune system. Frontiers Media S.A. 2019-04-02 /pmc/articles/PMC6454872/ /pubmed/31001119 http://dx.doi.org/10.3389/fphar.2019.00318 Text en Copyright © 2019 Gong, Hu, Qiao, Xu, Yang, Dang, Han, Guo, Chen and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gong, Xiaoxue
Hu, Hui
Qiao, Yi
Xu, Pengfei
Yang, Mengqi
Dang, Ruili
Han, Wenxiu
Guo, Yujin
Chen, Dan
Jiang, Pei
The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title_full The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title_fullStr The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title_full_unstemmed The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title_short The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
title_sort involvement of renin-angiotensin system in lipopolysaccharide-induced behavioral changes, neuroinflammation, and disturbed insulin signaling
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454872/
https://www.ncbi.nlm.nih.gov/pubmed/31001119
http://dx.doi.org/10.3389/fphar.2019.00318
work_keys_str_mv AT gongxiaoxue theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT huhui theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT qiaoyi theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT xupengfei theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT yangmengqi theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT dangruili theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT hanwenxiu theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT guoyujin theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT chendan theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT jiangpei theinvolvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT gongxiaoxue involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT huhui involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT qiaoyi involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT xupengfei involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT yangmengqi involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT dangruili involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT hanwenxiu involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT guoyujin involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT chendan involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling
AT jiangpei involvementofreninangiotensinsysteminlipopolysaccharideinducedbehavioralchangesneuroinflammationanddisturbedinsulinsignaling